1-Naphthylmethyl-4-(thiazolyl-2)-piperazines
US4112092A · kind A · utility
5Cited by
2References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 8, 1977 |
| Grant date | Sep 5, 1978 |
| Priority date | — |
| Expiry date | Apr 8, 1997 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Naphthyl derivatives of the formula: ##STR1## wherein: R.sub.1 is hydrogen, halogen, lower alkyl or lower alkoxy, and PA1 R.sub.2 and R.sub.3, which are the same or different, are hydrogen, lower alkyl or phenyl, PA1 Or R.sub.2 and R.sub.3 joined together are --CH .dbd. CH -- CH .dbd. CH--. These compounds are used as medicines, especially in the treatment of disorders of central nervous system (CNS), Parkinson's disease and cardiovascular disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.